Organ Transplantation, Donation, and Regenerative Medicine

Organ Transplantation

Organ transplantation was a significant medical success of the 20th century. The first successful kidney transplant was in 1954. In 1967, Dr. Christiaan Barnard performed the first heart transplant. This therapy has dramatically improved the quality of life for many patients and offers a chance of survival for others.

Who Can Donate?

Receptors are individuals who need a transplant. Donors can be:

  • Individuals declared brain dead: cessation of brain function, but organs remain viable for transplantation.
  • Living donors: donation of renewable tissues (bone marrow), parts of organs capable of regeneration (liver), or non-essential organs (kidney).

Individuals can express their wish to donate organs, and families usually honor this decision.

Spanish Legislation on Donation and Transplantation

Enacted in 1979 and updated multiple times, the core principles include:

  • Definition of brain death as legal death.
  • Respect for the deceased’s will regarding donation.
  • Independent medical diagnosis of death.
  • Altruistic and non-commercial nature of donation.
  • Donor anonymity.
  • Medical criteria for organ allocation.

Types of Transplants

Transplantation replaces a diseased organ with a healthy one. It is not always necessary to replace the entire organ.

  • Autologous transplant (autograft): Donor and recipient are the same individual (bone marrow, bones, blood vessels); no rejection risk.
  • Isotransplant: Donor and recipient are identical twins; no rejection risk.
  • Xenotransplantation: Donor and recipient are of different species; high rejection risk.
  • Allogeneic transplantation: Donor and recipient are of the same species but not genetically identical; most common type, with rejection risk.

Major Challenges in Transplantation

  • Immune Rejection: The recipient’s immune system recognizes the donor organ as foreign and attacks it. Immunosuppressive drugs are used to prevent rejection.
  • Organ Shortage: Spain has the highest donor rate (over 33 donors per million), but waiting times still exist, and some patients die before receiving a transplant.
  • Technical Limitations: Some organs and tissues are currently impossible to transplant (e.g., nerve cells).

Regenerative Medicine

Regenerative medicine uses stem cells to regenerate damaged tissues or organs without harming the patient. This process mimics natural tissue and organ development from a single cell (zygote).

Embryonic Development

  • Fertilization: Union of egg and sperm in the fallopian tube.
  • Stage 1: Sperm penetrates the egg; embryonic development begins.
  • Stage 2: Zygote divides into two cells.
  • Stage 3: Cells divide to form a morula (32 cells).
  • Stage 4: A cavity forms inside the morula, creating a blastocyst.
  • Stage 5: Inner cell mass forms (embryo proper), and outer cells form the placenta.
  • Stage 6: Embryo implants in the uterine wall (endometrium).

Developmental Stages

  • Embryonic/Prenatal Development: From zygote formation to birth.
  • Implantation: Embryo attaches to the endometrium.
  • Nervous System Formation: Cells differentiate to form the nervous system.
  • Organ Function: Fetal period begins (two months); organs mature and start functioning. Lungs are the last to become functional at birth.

Assisted Human Reproduction

Techniques to overcome infertility:

Artificial Insemination

Introduction of sperm into the female reproductive tract. Used for low sperm count, poor motility, or unfavorable female tract conditions.

In Vitro Fertilization and Embryo Transfer (IVF-ET)

Fertilization of an egg outside the woman’s body in a laboratory.

  1. Egg Retrieval: Hormone treatment stimulates egg production; eggs are retrieved from ovaries.
  2. Fertilization: Eggs are fertilized with sperm in a test tube.
  3. Embryo Transfer: Embryos are transferred to the uterus for implantation.

Excess embryos can be frozen in liquid nitrogen.

Multiple Pregnancies

IVF-ET can result in multiple pregnancies because several embryos are transferred to increase the chance of implantation.

Fate of Frozen Embryos

Frozen embryos can be donated to another woman, used for research (if medically unviable or after parental consent and legal timeframe), or remain frozen.

Sex Selection

Spanish law prohibits sex selection or choosing other characteristics, except to prevent genetic diseases or if another child has a serious illness.

Stem Cells and Regenerative Medicine

Stem cells are unspecialized cells capable of self-renewal and differentiation.

Types of Stem Cells

  • Totipotent: Can generate all cell types and a complete individual (zygote and first 8 cells).
  • Pluripotent: Can generate all cell types but not a complete individual (cells of the late blastocyst).
  • Multipotent: Can generate several cell types (adult stem cells).
  • Oligopotent: Can generate a limited number of cell types (some adult stem cells).

Regenerative Medicine Applications

  • Embryonic Stem Cells: Pluripotent, high potential for tissue regeneration.
  • Adult Stem Cells: Multipotent or oligopotent, found in various tissues.
  • Induced Pluripotent Stem Cells (iPSCs): Reprogrammed adult cells with pluripotency, a promising area of research.

Cloning

Cloning produces a genetically identical copy of a cell or organism.

Stages of Nuclear Transfer

  1. Obtain a differentiated cell from the individual to be cloned.
  2. Remove an egg from a female donor.
  3. Remove the egg’s nucleus.
  4. Transfer the donor cell’s nucleus into the enucleated egg.
  5. Culture the cell in a special medium to initiate embryo development.
  6. Transfer the embryo (morula or later stage) to a recipient’s uterus.
  7. Gestation results in a clone of the nucleus donor.

Applications and Limitations

  • Agriculture: Propagating desirable traits in plants and animals.
  • Research: Creating animal models for studying human diseases.
  • Ecology: Recovering endangered species.
  • Medicine: Cloning animals for organ transplantation (research focuses on preventing immune rejection).

Most countries oppose human reproductive cloning but regulate therapeutic cloning research.